English Title:
What Would It Take For Synopsys Stock To Move Higher?

中文标题：
神经病的股票要怎么才能高点?

English Content:
Shares of Synopsys (SNPS) rose 30% over the past month, compared with a 2.5% gain for the S&P 500. This climb followed the company's Investor Day on September 30 alongside new deals with OpenAI and Amazon. The climb offers a sign that buyers may be betting on AI. One part of that bet involves Design IP, the business that licenses ready-made pieces of chips. That division shrank last fiscal year. So is Design IP growing again? Synopsys's Design IP Returned To Growth In Fiscal Q3 This recovery is currently one quarter old. Design IP revenue rose about 11% from a year earlier in fiscal Q3 2026, following an 8.1% drop in fiscal 2025. Management said the segment grew on broad AI infrastructure demand, as AI pushes chip makers toward faster connections and more complex systems. Synopsys's die-to-die products connect separate chips inside one package. Management said these products are on pace to double year over year. The company has won more than 100 chip designs with them so far. Design IP Remains The Smaller Part Of Synopsys Design IP made up 25% of fiscal 2025 revenue. Design Automation, the company's chip-design tools, made up the rest. During fiscal Q3 2026, Design IP brought in $474 million of Synopsys's $2.477 billion revenue. Faster growth in Design IP would add to Synopsys's overall growth. Still, most of its revenue comes from Design Automation. During its fiscal Q3 call, management called mid-teens its long-term growth guide for IP for now. The higher growth opportunity lies with AI customers who want IP shaped to their own chips, management said. Synopsys is addressing that work by moving from licensing alone to licensing plus royalties, a model it calls Factory 2. Even after the past month's rise, the shares sit 7.5% below their 52-week high. They returned 12.7% over twelve months, against 21% for the S&P 500. What Could Stall Synopsys's Design IP Recovery? One good quarter following a year of decline is not yet a trend for Design IP. Synopsys's growth has to come from Design Automation alone if Design IP slips back. The shares trade at 88 times earnings, against 22.5 for the S&P 500. That price appears to assume growth across the company. Design IP has returned to growth on AI demand for now. Yet Synopsys has yet to show faster growth from charging AI customers royalties on custom IP. The number to watch in Synopsys's fiscal Q4 2026 report is Design IP's revenue growth from a year earlier. How To Act On SNPS? Now you know SNPS better. And that's our purpose: to make you informed before you invest your money. However, making a bet on a single stock carries its own risks.

中文正文：
精神病患者(SNPS)的股份在过去一个月中增长了30%,而S&P 500则增长了2.5%。 这次攀升是在9月30日公司投资者日之后, 攀登表明买家可能赌上AI. 该赌注的一部分涉及设计IP, 业务许可现成的芯片。 去年的财政年度,这个部门缩小了规模。 设计IP又增长了吗? Synopsys 设计 IP 在财政Q3中回归增长 这一恢复目前已有四分之一的历史。 设计IP收入比一年前的财政Q3 2026增长约11%,此前2025年财政下降了8.1%. 管理层说,该部分增长于广泛的AI基础设施需求,因为AI将芯片制造者推向更快的连接和更复杂的系统. Synophys的死对死产品在一个包内连接单独的芯片. 管理层说,这些产品的速度将逐年翻一番。 公司至今与他们一起赢得了100多个芯片设计. 设计IP Remains The Synopsys Design IP占2025年财政收入的25%. 设计自动化(Design Automation),该公司的芯片设计工具,组成了其余部分. 在财政Q3 2026期间,设计IP带来了 四亿七千四百万的Synopsys24.77亿收入. Design IP的更快增长将增加Synopsis的整体增长. 尽管如此,它的大部分收入来自Design Automation. 在其财政Q3呼吁中,管理层称十九年代中期是目前IP的长期增长指南. 管理层说,增长机会较大的是AI客户,他们希望IP被塑造成自己的芯片。 精神病患者正在处理这项工作,从发放许可证转向发放许可证和特许权使用费,这是一种称之为第二工厂的模式。 即便在过去一个月的崛起之后,股票也低于其52周的高点7.5%. 他们12个月内返回了12.7%,而S & P 500为21%。 Stall Synophys的IP设计恢复能有什么? 在一年的衰退之后,四分之一的好时间还不是设计综合方案的趋势。 如果Design IP滑回,Synophs的成长必须仅来自Design Automation. 股票交易收入为88倍,而S&P 500为22.5倍。 这个价格似乎假设整个公司的增长。 设计IP在AI需求下恢复了现在的成长. 然而,Synophys还没有表现出更快的增长,从对定制IP收取AI客户版税. 在Synopsys的财政Q4 2026报告中观看的号码是: 设计IP的收入比一年前增长. 如何在SNPS上行动? 现在你更了解SNPS了 这就是我们的目的:在你投资之前,先通知你。 然而,在单一股票上下注本身就有风险.